The current P/E ratio for Vericel stock as of Apr 2, 2025 is 211.0. This is calculated based on the current EPS of $0.21 and the stock price of $44.31 per share.
The average historical PE ratio of Vericel for the last five years is 1475.91. The current price-to-earnings ratio of 211.0 is 86% less than the historical average. In the past five years, VCEL's PE ratio reached its highest point in the Sep 2021 quarter at 4,880, when the stock price was $48.8 and the EPS was $0.01. The lowest point was recorded in the Dec 2024 quarter, when it reached 261.48 with a price of $54.91 and an EPS of $0.21.
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 261.48 | N/A | $54.91 | $0.21 |
2023 | N/A | N/A | $35.61 | -$0.07 |
2022 | N/A | N/A | $26.34 | -$0.35 |
2021 | N/A | N/A | $39.3 | -$0.16 |
2020 | 514.67 | N/A | $30.88 | $0.06 |
2019 | N/A | N/A | $17.4 | -$0.22 |
2018 | N/A | N/A | $17.4 | -$0.2 |
2017 | N/A | N/A | $5.45 | -$0.52 |
2016 | N/A | N/A | $3 | -$1.18 |
2015 | N/A | N/A | $2.58 | -$0.97 |
2014 | N/A | N/A | $3.04 | -$2.23 |
2013 | N/A | N/A | $3.23 | -$6.95 |
2012 | N/A | N/A | $25.2 | -$16.25 |
2011 | N/A | N/A | $36.4 | -$10.18 |
2010 | N/A | N/A | $29.8 | -$11.8 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | 261.48 | -56.68% | $54.91 | $0.21 |
Sep 2024 | 603.57 | -86.84% | $42.25 | $0.07 |
Jun 2024 | 4,588 | N/A | $45.88 | $0.01 |
Mar 2024 | N/A | N/A | $52.02 | $0 |
Dec 2023 | N/A | N/A | $35.61 | -$0.07 |
Sep 2023 | N/A | N/A | $33.52 | -$0.22 |
Jun 2023 | N/A | N/A | $37.57 | -$0.28 |
Mar 2023 | N/A | N/A | $29.32 | -$0.36 |
Dec 2022 | N/A | N/A | $26.34 | -$0.35 |
Sep 2022 | N/A | N/A | $23.2 | -$0.38 |
Jun 2022 | N/A | N/A | $25.18 | -$0.35 |
Mar 2022 | N/A | N/A | $38.22 | -$0.24 |
Dec 2021 | N/A | N/A | $39.3 | -$0.16 |
Sep 2021 | 4,880 | 1,759.05% | $48.8 | $0.01 |
Jun 2021 | 262.5 | -52.75% | $52.5 | $0.2 |
Currently, VCEL's PE ratio is lower than the 5 and 10-year averages.
When compared to its peer stock RPRX, VCEL's PE ratio is higher.
Stock name | PE ratio | Market cap |
---|---|---|
RPRX Royalty Pharma plc | 16.47 | $18.23B |
VCEL Vericel Corp | 209.81 | $2.2B |
NEOG Neogen Corp | N/A | $1.76B |
NURO NeuroMetrix Inc | N/A | $9.19M |
The price to earnings ratio for VCEL stock is 211 as of Apr 2, 2025.
The average PE ratio for VCEL stock over the past 5 years is 1475.91.
Over the last five years, the quarterly PE ratio reached a historic high of 4,880 in the Sep 2021 quarter.
The current price to earnings ratio of VCEL is 86% lower than the 5-year historical average.
VCEL's PE ratio of 211 is considered high because the company's stock price is trading at a higher multiple of earnings.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Apr 2, 2025), Vericel's stock price is $44.31. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.21. Therefore, Vericel's price to earnings ratio for today is 211. PE RATIO(211) = STOCK PRICE($44.31) / TTM EPS($0.21)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.